Navigation Links
Tuberculosis Drug Resistance 'alarming' in India

An alarming 20 percent of the people availing re-treatment of tuberculosis are at the risk// of developing drug resistance in India. According to a leading global health advocacy, India witness nearly 1.8 million fresh cases every year.

On the eve of the World TB Day, March 24, the Global Health Advocates (GHA), a Switzerland-based non-profit body, said that TB drug resistance is becoming a major threat for several countries and India is one of the forerunners.

"After Russia that has recorded a whopping 41 percent drug resistance among the re-treatment category, India and South Africa are facing the wrath with 20 percent of the patients of the same category at risk," said GHA president Bobby John.

Countries with over 10 percent risk include Brazil, Nigeria, Pakistan, Myanmar, Uganda, Thailand and Philippines.

Citing latest data provided by the World Health Organization (WHO), John said: "Nearly 196,000 people registered themselves for re-treatment for TB in 2004 of which 39,000 showed drug resistance.

"Only 50 percent of those who availed of re-treatment were completely cured and 6.9 percent died. It is certainly alarming that close to 43 percent patients need extensive care," John told IANS.

He said India has a considerably good track record in providing TB treatment but there is a need for better health infrastructure to deal with this menace.

"Once a patient becomes drug resistant, he will spread it to many people and you can imagine the economic loss," John warned.

Earlier this month, the Indian government said it had cleared Rs.11.56 billion for the Revised National Tuberculosis Program (RNTCP)-Phase II.

"The RNTCP Phase-II of the World Bank Project has been approved by the government for the period October 2006 to September 2011 for a total outlay of Rs.11.56 billion," Minister of State for Health P. Lakshmi had recently told the Rajya Sabha.

"This includes credit of Rs.7.65 billion from the World Bank and a grant of Rs.1.99 billion for commodity assistance of anti-TB drugs from the Department of International Development (DFID)," she had said.

The RNTCP, popularly known as DOTS program, was introduced in the country in 1997 in a phased manner to achieve a cure rate of 85 percent of new sputum positive cases and to detect at least 70 percent of such cases. The entire country was covered by March 2006.

Till date, 6.7 million patients have received DOTS treatment averting more than 1.22 million deaths.

TB is still a major cause of death worldwide and 1.6 million people had succumbed to the disease in 2005, WHO said in Geneva Thursday.

Source-IANS
'"/>




Related medicine news :

1. PCR emerging as a promising technique for Diagnosing Urinary Tuberculosis
2. Defending against Tuberculosis
3. Easier Tests To Detect Tuberculosis
4. Smoking Increases The Risk Of Developing Tuberculosis Infection
5. Gene Target For Tuberculosis Identified
6. WHO declares Tuberculosis – ‘An Emergency’ in Afrca
7. New Vaccine Targeted At Effective Treatment Against Tuberculosis
8. Time for A.R.Rahman to rock the Tuberculosis Awareness Programme
9. BCG vaccine for both Protection and treatment of Tuberculosis
10. Diagnostic Procedure For Tuberculosis Made Easy
11. PA-824 drug effective against Tuberculosis
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:1/20/2017)... ... , ... Bionic Sports Nutrition LLC, an American company devoted to developing high-quality ... January ECRM Trade Show in Hilton Head, SC. , Bionic Sports Nutrition manufactures ... its products to all clients at reasonable prices. At the ECRM trade show, it ...
(Date:1/20/2017)... ... January 20, 2017 , ... ATP Science, ... everyday lives, recently attended the January ECRM Trade Show in Hilton Head, SC, ... for its large range of supplements that keep the body functioning at its ...
(Date:1/20/2017)... boca raton florida (PRWEB) , ... January 20, 2017 , ... ... trial at the Dana Farber Cancer Institute. For Betsy, the clinical trial has ... and her cancer has not worsened. , Betsy Brauser was diagnosed with ovarian ...
(Date:1/20/2017)... ... January 20, 2017 , ... Vitamin Well has launched ... The drinks have been produced in collaboration with Zlatan Ibrahimovic and have been ... , After a successful launch in Sweden last year, the next generation sports ...
(Date:1/20/2017)... ... 20, 2017 , ... “The Angel”: a heartwarming and earnest tale of ... of his children. “The Angel” is the creation of published author, Marjorie Lund-Fontaine, a ... and impassioned writer. , When asked of her new book, Marjorie says, “‘The Angel’ ...
Breaking Medicine News(10 mins):
(Date:1/21/2017)... Mass. , Jan. 20, 2017 /PRNewswire/ ... Keystone Symposia Conference, "PI3K Pathways in Immunology, ... Inc. (NASDAQ: INFI ) ... immuno-oncology development candidate that selectively inhibits phosphoinositide-3-kinase-gamma ... able to help overcome resistance to checkpoint ...
(Date:1/20/2017)... -- Research and Markets has announced the addition ... BMP, BUN Creatinine, Electrolyte Testing, HbA1c Testing, Comprehensive Metabolic Panel, Liver ... - 2024" report to their offering. ... The global clinical laboratory testing market ... Introduction of innovative solutions on the grounds of maximum efficiency and ...
(Date:1/20/2017)... 2017 Stock-Callers.com today evaluates the following ... ), Novo Nordisk A/S (NYSE: NVO ), Sucampo ... Holdings Inc. (NASDAQ: PTX ). These stocks belong ... th , 2017, finishing near its session lows. As per ... 0.7%, while shares of health care companies in the S&P ...
Breaking Medicine Technology: